Xenter Unveils Groundbreaking Investigational Dual Sensor Wireless GuideWire for Minimally Invasive TAVR Procedures at TCT 2023 venturebeat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from venturebeat.com Daily Mail and Mail on Sunday newspapers.
Published: May 07, 2021
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health-
SALT LAKE CITY (BUSINESS WIRE) Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are
Robert S. Langer, an Institute Professor at MIT and the most cited engineer in history and 4th most cited individual in any field who has authored more than 1,500 scientific papers. He is also a co-founder and board member of Moderna.
Search jobs 07-Apr-2021 Xenter, Inc., Announces Company Launch and Strategy as the First Start-Up “Device/Data/Drug” Medical Technology Company
-New technology will advance interventional medicine by 30 years, according to industry veteran Jim Tobin-
SALT LAKE CITY (BUSINESS WIRE) #DigitalHealth (www.XenterMD.com) today announced its formal launch in Salt Lake City, Utah. Founded in 2020 by seasoned life sciences entrepreneur
Richard J. Linder, Xenter is innovating new wireless technologies and techniques for interventional cardiology, interventional radiology, and neurointerventional radiology. Additionally, Xenter is launching a digital health platform that will leverage new wireless interventional devices that provide physiologic data and images simultaneously and enable patients to have access and control of their medical data.